Webinar – Skin based Technologies for Children and Adolescentes

Home / Educational resources / Webinars / EPTRI Paediatric Medical Device Platform – Webinar series / Webinar – Skin based Technologies for Children and Adolescentes

23rd
September

23rd September 2025, 3.30pm – 5.00pm, BST

Skin based Technologies for Children and Adolescents
Chair: Sandra Brasil, European Paediatric Transnational Research Infrastructure, EPTRI (Belgium)

EPTRI is delighted to welcome you to our ninth webinar on Skin based Technologies for Children and Adolescents. Our 90 minute webinar will focus on the newest innovations, the use of artificial intelligence and its regulation on medical devices for skin therapies for children and adolescents.. We look forward to seeing you at our next exciting webinar event.

Speakers

Stephen Gilbert, Technische Universität Dresden, Germany

Stephen Gilbert worked in senior MedTech and Digital Heath roles in industry for 5 years, before returning to academia in 2022 in Dresden, Germany, where he teachs and conduct research. My research goals are the advancement of regulatory science in digital medicine and AI-enabled medical devices. Innovative digital approaches in healthcare must be accompanied by innovative oversight approaches to ensure speed to market, to maximise the access of patients to life saving treatments while at the same time ensuring safety on market.

Michael J. Cork, BSc MB PhD FRCP, Sheffield Children’s Hospital (SCH) NHS Trust, UK

Professor Michael J. Cork is head of Sheffield Dermatology Research; in the Dept. of Infection, Immunity & Cardiovascular Disease; Faculty of Medicine, Dentistry & Health; at The University of Sheffield, UK. He is a Consultant Dermatologist to Sheffield Children’s Hospital (SCH) NHS Trust and to Sheffield Teaching Hospitals (STH) NHS Trust.

He specialises in treating children and adults with the most severe atopic dermatitis and sees patients from anywhere in the UK. At Sheffield Children’s Hospital he leads an integrated atopic dermatitis – allergy – psychiatry service, designed to manage the most complex patients. He leads clinical trials of new treatments for atopic dermatitis at the Clinical Research Facilities at SCH for children and at STH for adults. He is Chief Investigator in the UK for many of the trials for new biologics, small molecules and topicals for atopic dermatitis.

With Dr. Simon Danby, they have created a dedicated clinical research facility for skin barrier, biomarker research. Their Skin Barrier Team have developed a research facility that has developed a unique combination of techniques to assess how topical wash products, emollients and topical/systemic pharmaceutical agents affect the integrity of the skin barrier and inflammation in normal and AD skin.